Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,967 | -18,073 | -13,909 | -9,955 | -5,386 |
| Depreciation Amortization | 13 | 43 | 31 | 22 | 13 |
| Accounts payable and accrued liabilities | -15 | -861 | -739 | -1,087 | -543 |
| Other Working Capital | -76 | -884 | -242 | -270 | -282 |
| Other Operating Activity | 1,167 | 1,811 | 1,307 | 1,016 | 267 |
| Operating Cash Flow | $-3,879 | $-17,964 | $-13,552 | $-10,274 | $-5,930 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -33 | -69 | -94 | -93 | -65 |
| PPE Investments | N/A | -96 | -89 | -89 | N/A |
| Other Investing Activity | 0 | 3,717 | 3,149 | 949 | 0 |
| Investing Cash Flow | $-33 | $3,553 | $2,966 | $767 | $-66 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 80 | N/A | 0 | N/A |
| Other Financing Activity | 0 | -11 | -11 | -11 | -11 |
| Financing Cash Flow | $N/A | $69 | $-11 | $-11 | $-11 |
| Beginning Cash Position | 13,893 | 28,235 | 28,235 | 28,235 | 28,235 |
| End Cash Position | 9,981 | 13,893 | 17,638 | 18,717 | 22,228 |
| Net Cash Flow | $-3,912 | $-14,342 | $-10,597 | $-9,518 | $-6,007 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,879 | -17,964 | -13,552 | -10,274 | -5,930 |
| Capital Expenditure | N/A | -96 | -89 | -89 | N/A |
| Free Cash Flow | -3,879 | -18,060 | -13,641 | -10,363 | -5,930 |